High cytotoxic and specific migratory potencies of senescent CD8 +CD57+ cells in HIV-infected and uninfected individuals

Journal of Immunology

Volumn 177, Issue 8, 2006, Pages 5145-5154

  Le Priol, Yannick ^a   Puthier, Denis ^b   Lécureuil, Cédric ^a   Combadière, Christophe ^a   Debré, Patrice ^a   Nguyen, Catherine ^b   Combadière, Béhazine ^b,c  

^a INSERM   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

^c SORBONNE UNIVERSITÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD57 ANTIGEN; CELL ADHESION MOLECULE; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CXCR4; CYTOKINE; GAMMA INTERFERON; GRANULYSIN; GRANZYME A; GRANZYME B; INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 7; PERFORIN; T LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ANTIGEN SPECIFICITY; APOPTOSIS; ARTICLE; CD8+ T LYMPHOCYTE; CELL ADHESION; CELL CYCLE REGULATION; CELL INTERACTION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOSKELETON; CYTOTOXICITY; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; INFECTION; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; UNINDEXED SEQUENCE;

EID: 33749512800     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.177.8.5145     Document Type: Article

References (59)

1. Fahey, J. L., H. Prince, M. Weaver, J. Groopman, B. Visscher, K. Schwartz, and R. Detels. 1984. Quantitative changes in T helper or T suppressor/cytoloxic lymphocyte subsets that distinguish acquired immune deficiency syndrome from other immune subset disorders. Am. J. Med. 76: 95-100.
2. Munoz, A., V. Carey, A. J. Saah, J. P. Phair, L. A. Kingsley, J. L. Fahey, H, M. Ginzburg, and B. F. Polk. 1988. Predictors of decline in CD4 lymphocytes in a cohort of homosexual men infected with human immunodeficiency virus. J. Acquired Immune Defic. Syndr. 1: 396-404.
3. Giorgi, J. V., and R. Detels. 1989. T-cell subset alterations in HIV-infected homosexual men: NIAID Multicenter AIDS cohort study. Clin. Immunol. Immunopathol. 52: 10-18.
4. + T-cell responses: relationship to viral load in untreated HIV infection. J. Virol. 75: 11983-11991.
5. + T cell proliferation is coupled to perform expression and is maintained in nonprogressors. Nat. Immunol. 3: 1061-1068.
6. Pantaleo, G., and R. A. Koup. 2004. Correlates of immune protection in HIV-1 infection: what we know, what we don't know, what we should know. Nat. Med. 10: 806-810.
7. Betts, M. R., B. Exley, D. A. Price, A. Bansal, Z. T. Camacho, V. Teaberry, S. M. West, D. R. Ambrozak, G. Tomaras, M. Roederer, et al. 2005. Characterization of functional and phenotypic changes in anti-Gag vaccine-induced T cell responses and their role in protection after HIV-1 infection. Proc. Natl. Acad. Sci. USA 102: 4512-4517.
8. Crawford, D. H., P. Brickell, N. Tidman, I. McConnell, A. V. Hoffbrand, and G. Janossy. 1981. Increased numbers of cells with suppressor T cell phenotype in the peripheral blood of patients with infectious mononucleosis. Clin. Exp. Immunol. 43: 291-297.
9. Schooley, R. T., M. S. Hirsch, R. B. Colvin, A. B. Cosimi, N. E. Tolkoff-Rubin, R. T. McCluskey, R. C. Burton, P. S. Russell, J. T. Herrin, F. L. Delmonico, et al. 1983. Association of herpesvirus infections with T-lymphocyte-subset alterations, glomerulopathy, and opportunistic infections after renal transplantation. N. Engl. J. Med. 308: 307-313.
10. Joly, P., J. M. Guillon, C. Mayaud, F. Plata, I. Theodorou, M. Denis, P. Debre, and B. Autran. 1989. Cell-mediated suppression of HIV-specific cytotoxic T lymphocytes. J. Immunol. 143: 2193-2201.
11. + lymphocytes from AIDS patients inhibits T cell cytotoxicity. Eur. J. Immunol. 21: 737-741.
12. + lymphocytes in human immunodeficiency virus infection produce an inhibitor of cytotoxic functions. Am. J. Respir. Crit. Care Med. 149: 972-980.
13. + T lymphocytes are enriched in antigen-specific T cells capable of down-modulating cytotoxic activity. Int. Immunol. 10: 311-323.
14. Lanier, L. L., A. M. Le, J. H. Phillips, N. L. Warner, and G. F. Babcock. 1983. Subpopulations of human natural killer cells defined by expression of the Leu-7 (HNK-1) and Leu-11 (NK-15) antigens. J. Immunol. 131: 1789-1796.
15. Nagler, A., L. L. Lanier, S. Cwirla, and J. H. Phillips. 1989. Comparative studies of human FcRIII-positive and -negative natural killer cells. J. Immunol. 143: 3183-3191.
16. Abo, T., and C. M. Balch. 1981. A differentiation antigen of human NK and K cells identified by a monoclonal antibody (HNK-1). J. Immunol. 127: 1024-1029.
17. Lewis, D. E., J. M. Puck, G. F. Babcock, and R. R. Rich. 1985. Disproportionate expansion of a minor T cell subset in patients with lymphadenopathy syndrome and acquired immunodeficiency syndrome. J. Infect. Dis. 151: 555-559.
18. + cells in acquired immune deficiency syndrome (AIDS), AIDS-related complex, and asymptomatic homosexuals. J. Clin. Immunol. 6: 502-509.
19. Wursch, A. M., J. W. Gratama, J. M. Middeldorp, C. Nissen, A. Gratwohl, B. Speck, J. Jansen, J. D'Amaro, T. H. The, and G. C. De Gast. 1985. The effect of cytomegalovirus infection on T lymphocytes after allogeneic bone marrow transplantation. Clin. Exp. Immunol. 62: 278-287.
20. Evans, T. G., E. G. Kallas, A. E. Luque, M. Menegus, C. McNair, and R. J. Looney. 1999. Expansion of the CD57 subset of CD8 T cells in HIV-1 infection is related to CMV serostatus. AIDS 13: 1139-1141.
21. + suppressor lymphocytes in the blood of long-term surviving patients after allogeneic bone marrow transplantation. J. Immunol. 137: 2180-2189.
22. + lymphocytes in patients with rheumatoid arthritis: correlation with duration of disease. Arthritis Rheum. 36: 608-612.
23. Brenchley, J. M., N. J. Karandikar, M. R. Betts, D. R. Ambrozak, B. J. Hill, L. E. Crotty, J. P. Casazza, J. Kuruppu, S. A. Migueles, M. Connors, et al. 2003. Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T bells. Blood 101: 2711-2720.
24. Combadiere, B., S. Faure, B. Autran, P. Debre, and C. Combadiere. 2003. The chemokine receptor CX3CR1 controls homing and anti-viral potencies of CD8 effector/memory T lymphocytes in HIV-infected patients. AIDS 17: 1279-1290.
25. Bertucci, F., K. Bernard, B. Loriod, Y. C. Chang, S. Granjeaud, D. Birnbaum, C. Nguyen, K. Peck, and B. R. Jordan. 1999. Sensitivity issues in DNA array-based expression measurements and performance of nylon microarrays for small samples. Hum. Mol. Genet. 8: 1715-1722.
26. Nguyen, C., D. Rocha, S. Granjeaud, M. Baldit, K. Bernard, P. Naquet, and B. R. Jordan. 1995. Differential gene expression in the murine thymus assayed by quantitative hybridization of arrayed cDNA clones. Genomics 29: 207-216.
27. Bernard, K., N. Auphan, S. Granjeaud, G. Victorero, A. M. Schmitt-Verhulst, B. R. Jordan, and C. Nguyen. 1996. Multiplex messenger assay: simultaneous, quantitative measurement of expression of many genes in the context of T cell activation. Nucleic Acids Res. 24: 1435-1442.
28. Eisen, M. B., P. T. Spellman, P. O. Brown, and D. Botstein. 1998. Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. USA 95: 14863-14868.
29. Hurlin, P. J., C. Queva, P. J. Koskinen, E. Steingrimsson, D. E. Ayer, N. G. Copeland, N. A. Jenkins, and R. N. Eisenman. 1995. Mad3 and Mad4: novel Max-interacting transcriptional repressors that suppress c-myc dependent transformation and are expressed during neural and epidermal differentiation. EMBO J. 14: 5646-5659.
30. Batliwalla, F. M., B. A. Bateman, D. Serrano, D. Murray, S. Macphail, V. C. Maino, J. C. Ansel, P. K. Gregersen, and C. A. Armstrong. 1998. A 15-year follow-up of AJCC stage III malignant melanoma patients treated postsurgically with Newcastle disease virus (NDV) oncolysate and determination of alterations in the CD8 T cell repertoire. Mol. Med. 4: 783-794.
31. + lymphocytes from bone marrow transplanted patients inhibits cell-mediated cytolysis. Blood 77: 2237-2241.
32. + CD8 T lymphocytes correlates with reduced viral plasma RNA after primary HIV infection. AIDS 13: 891-899.
33. + T cell responses against human cytomegalovirus proteins pp65 and immediate early 1 shows similarities in precursor frequency, oligoclonality, and phenotype. J. Infect. Dis. 185: 1025-1034.
34. Khan, N., N. Sheriff, M. Cobbold, R. Braton, J. A. Ainsworth, A. J. Sinclair, L. Nayak, and P. A. Moss. 2002. Cytomegalovirus seropositivity drives the CD8 T cell repertoire toward greater clonality in healthy elderly individuals. J. Immunol. 169: 1984-1992.
35. + T cells vary in differentiation phenotype in different persistent virus infections. Nat. Med. 8: 379-385.
36. Appay, V., L. Papagno, C. A. Spina, P. Hansasuta, A. King, L. Jones, G. S. Ogg, S. Little, A. J. McMichael, D. D. Richman, and S. L. Rowland-Jones. 2002. Dynamics of T cell responses in HIV infection. J. Immunol. 168: 3660-3666.
37. Pena, S. V., D. A. Hanson, B. A. Carr, T. J. Goralski, and A. M. Krensky. 1997. Processing, subcellular localization, and function of 519 (granulysin), a human late T cell activation molecule with homology to small, lytic, granule proteins. J. Immunol. 158: 2680-2688.
38. Jongstra, J., T. J. Schall, B. J. Dyer, C. Clayberger, J. Jorgensen, M. M. Davis, and A. M. Krensky. 1987. The isolation and sequence of a novel gene from a human functional T cell line. J. Exp. Med. 165: 601-614.
39. Deng, A., S. Chen, Q. Li, S. C. Lyu, C. Clayberger, and A. M. Krensky. 2005. Granulysin, a cytolytic molecule, is also a chemoattractant and proinflammatory activator. J. Immunol. 174: 5243-5248.
40. Sallusto, F., D. Lenig, R. Forster, M. Lipp, and A. Lanzavecchia. 1999. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401: 708-712.
41. Champagne, P., G. S. Ogg, A. S. King, C. Knabenhans, K. Ellefsen, M. Nobile, V. Appay, G. P. Rizzardi, S. Fleury, M. Lipp, et al. 2001. Skewed maturation of memory HIV-specific CD8 T lymphocytes. Nature 410: 106-111.
42. Sallusto, F., E. Kremmer, B. Palermo, A. Hoy, P. Ponath, S. Qin, R. Forster, M. Lipp, and A. Lanzavecchia. 1999. Switch in chemokine receptor expression upon TCR stimulation reveals novel homing potential for recently activated T cells. Eur. J. Immunol. 29: 2037-2045.
43. + cytotoxic effector lymphocytes that are defined by CX3CR1 expression. J. Immunol. 168: 6173-6180.
44. Guillon, J. M., B. Autran, M. Denis, P. Fouret, F. Plata, C. M. Mayaud, and G. M. Akoun. 1988. Human immunodeficiency virus-related lymphocytic alveolitis. Chest 94: 1264-1270.
45. Guillon, J. M., P. Fouret, C. Mayaud, F. Picard, M. Raphael, J. L. Touboul, M. P. Chaunu, J. J. Hauw, and G. Akoun. 1987. Extensive T8-positive lymphocytic visceral infiltration in a homosexual man. Am. J. Med. 82: 655-661.
46. Itescu, S., L. J. Brancato, J. Buxbaum, P. K. Gregersen, C. C. Rizk, T. S. Croxson, G. E. Solomon, and R. Winchester. 1990. A diffuse infiltrative CD8 lymphocytosis syndrome in human immunodeficiency virus (HIV) infection: a host immune response associated with HLA-DR5. Ann. Intern. Med. 112: 3-10.
47. Tong, N., S. W. Perry, Q. Zhang, H. J. James, H. Guo, A. Brooks, H. Bal, S. A. Kinnear, S. Fine, L. G. Epstein, et al. 2000. Neuronal fractalkine expression in HIV-1 encephalitis: roles for macrophage recruitment and neuroprotection in the central nervous system. J. Immunol. 164: 1333-1339.
48. Pereira, C. F., J. Middel, G. Jansen, J. Verhoef, and H. S. Nottet. 2001. Enhanced expression of fractalkine in HIV-1 associated dementia. J. Neuroimmunol. 115: 168-175.
49. Foussat, A., L. Bouchet-Delbos, D. Berrebi, I. Durand-Gasselin, A. Coulomb-L'Hermine, R. Krzysiek, P. Galanaud, Y. Levy, and D. Emilie. 2001. Deregulation of the expression of the fractalkine/fractalkine receptor complex in HIV-1-infected patients. Blood 98: 1678-1686.
50. Kanazawa, N., T. Nakamura, K. Tashiro, M. Muramatsu, K. Morita, K. Yoneda, K. Inaba, S. Imamura, and T. Honjo. 1999. Fractalkine and macrophage-derived chemokine: T cell-attracting chemokines expressed in T cell area dendritic cells. Eur. J. Immunol. 29: 1925-1932.
51. Papadopoulos, E. J., C. Sassetti, H. Saeki, N. Yamada, T. Kawamura, D. J. Fitzhugh, M. A. Saraf, T. Schall, A. Blauvelt, S. D. Rosen, and S. T. Hwang. 1999. Fractalkine, a CX3C chemokine, is expressed by dendritic cells and is up-regulated upon dendritic cell maturation. Eur. J. Immunol. 29: 2551-2559.
52. Newton, R. A., and N. Hogg. 1998. The human S100 protein MRP-14 is a novel activator of the β2 integral Mac-1 on neutrophils. J. Immunol. 160: 1427-1435.
53. Kanai, T., E. K. Thomas, Y. Yasutomi, and N. L. Letvin. 1996. IL-15 stimulates the expansion of AIDS virus-specific CTL. J. Immunol. 157: 3681-3687.
54. Shaulian, E., and M. Karin. 2002. AP-1 as a regulator of cell life and death. Nat. Cell Biol. 4: E131-E136.
55. - compartment. Blood 98: 2817-2827.
56. Raitakari, M., R. D. Brown, D. Sze, E. Yuen, L. Barrow, M. Nelson, B. Pope, W. Esdale, J. Gibson, and D. E. Joshua. 2000. T-cell expansions in patients with multiple myeloma have a phenotype of cytotoxic T cells. Br. J. Haematol. 110: 203-209.
57. - lymphocytes in the lung and blood of HIV-infected subjects. Clin. Immunol. 117: 294-301.
58. Shinomiya, N., Y. Koike, H. Koyama, E. Takayama, Y. Habu, M. Fukasawa, S. Tanuma, and S. Seki. 2005. Analysis of the susceptibility of CD57 T cells to CD8-mediated apoptosis. Clin. Exp. Immunol. 139: 268-278.
59. bright natural suppressor cell line on human breast cancer cell death and growth. Int. J. Oncol. 23: 205-212.